Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.78 CAD | -1.37% | -1.53% | +11.37% |
Mar. 22 | Knight Therapeutics Price Target Raised to $7 at RBC | MT |
Mar. 21 | Knight Therapeutics Reports Fourth Quarter Results | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.37% | 429M | |
+11.18% | 9.08B | |
-15.94% | 4.57B | |
+18.47% | 3.9B | |
+1.89% | 3.69B | |
+28.61% | 2.62B | |
-24.63% | 2.34B | |
-29.37% | 2.14B | |
+2.55% | 1.84B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- GUD Stock
- News Knight Therapeutics Inc.
- Knight Therapeutics : Says Health Canada Approves Neratinib for Treatment of HER2-Positive Breast Cancer